Vishnu K: The Growing Role of RET-He in Modern Hematology
Vishnu K, Hematopathology Postgraduate at Nitte University, shared a post on LinkedIn:
“RET-He: Precision Anemia Management.
Early detection is the key to effective anemia management. Reticulocyte Hemoglobin Equivalent (RET-He) is emerging as a powerful biomarker that assesses the real-time availability of iron for red blood cell production—often identifying iron deficiency before changes in hemoglobin become apparent.
By enabling earlier diagnosis, monitoring response to iron therapy within days, and supporting anemia management in conditions such as chronic kidney disease, inflammation, pregnancy, and pediatric populations, RET-He is advancing a more precise and personalized approach to patient care.
As laboratory medicine continues to evolve, innovative biomarkers like RET-He are helping clinicians make faster, evidence-based decisions that improve patient outcomes.
Precision diagnostics. Timely intervention. Better patient care.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering